Prognostic relevance of molecular measurable residual disease detection in AML with mutated CEBPA

• Christian M. Vonk,
• Emma L. Boertjes,
• Francois G. Kavelaars,
• Melissa Rijken,
• Jolinda M. L. Konijnenburg,
• Roxanne E. Cromwell,
• Bob Löwenberg,
• Tim Grob,
• Peter J. M. Valk

Affiliations

Christian M. Vonk

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands

Emma L. Boertjes

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands

Francois G. Kavelaars

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands

Melissa Rijken

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands

Jolinda M. L. Konijnenburg

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands

Roxanne E. Cromwell

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands

Bob Löwenberg

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands

Tim Grob

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands

Peter J. M. Valk

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands